Effect of oral Kohki tea on bladder dysfunction induced by severe partial outlet obstruction

Journal of Urology

Volumn 167, Issue 5, 2002, Pages 2260-2266

  Levin, Robert M ^a,b   Kawashima, Yoshihito ^a,b   Leggett, Robert E ^a,b   Whitbeck, Catherine ^a,b   Horan, Patrick ^a,b   Mizutani, Kenji ^a,b  

^a STRATTON VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Bladder; Bladder neck obstruction; Ca(2+) transporting ATPase; Plant extracts; Rabbits

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTIOXIDANT; ENGELHARDTIA CHRYSOLEPIS EXTRACT; GLYCOSIDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLADDER CONTRACTION; BLADDER FUNCTION; BLADDER NECK STENOSIS; CONTROLLED STUDY; CYSTOMETRY; MEDICINAL PLANT; NONHUMAN; PHYTOTHERAPY; PLANT LEAF; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SMOOTH MUSCLE CONTRACTION; TEA; TREATMENT OUTCOME;

ENGELHARDTIA CHRYSOLEPIS;

EID: 0036227669     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65139-7     Document Type: Article

References (42)

1. The physical basis of obstructive uropathy
2. Benign prostatic hyperplasia
3. Acute biochemical and functional alterations in the partially obstructed rabbit urinary bladder
4. The functional effect of mild outlet obstruction on the rabbit urinary bladder
5. The guinea pig as a model of gradual urethral obstruction
6. The effect of bladder outlet obstruction on tissue oxygen tension and blood flow in the pig bladder
7. Canine bladder blood flow and oxygenation: Changes induced by filling, contraction and outlet obstruction
8. Blood flow of the urinary bladder: Effects of outlet obstruction and correlation with bioenergetic metabolism
9. Experimental models of bladder obstruction
10. Contractility and phenotype transitions in serosal thickening of obstructed rabbit bladder
11. The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs
12. 2+ homeostasis, cell death, proliferation, and differentiation
13. Oxidants in mitochondria: From physiology to diseases
14. An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
15. Correlation of ischemia/reperfusion and partial outlet obstruction induced spectrin proteolysis by calpain with contractile dysfunction in the rabbit bladder
16. Calpain: New perspectives in molecular diversity and physiological-pathological involvement
17. Fatty acid profiles in normal and obstructed rabbit bladder smooth muscle and mucosa
18. Mechanisms of phospholipase A2 activation and neuronal injury
19. Oxygen free radical-induced lipid peroxidation in overdistention of the rabbit urinary bladders
20. Correlation of lipid peroxidation with energetic metabolism and contractile function in overdistention of the rabbit urinary bladder
21. A scientific basis for the therapeutic effects of Pygium africanum and Serenoa repens
22. Effect of oral Tadenan treatment on rabbit bladder structure and function after bladder outlet obstruction
23. Antioxidative substances in leaves of Polygonum Hudopiper
24. Effect of astilbin in tea processed from leaves of Engelhardtia chrysolepis on the serum and liver lipid concentrations and on the erythrocyte and liver antioxidative enzyme activities of rats
25. Enhancement of the vanadate-stimulated release of lipoprotein lipase activity by astilbin from the leaves of Engelhardtia chrysolepis
26. Inhibition of aldose reductase and sorbitol accumulation by astilbin and taxifolin dihydroflavonols in Engelhardtia chrysolepis
27. Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes
28. Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis
29. Mechanisms of bladder smooth muscle hypertrophy and decompensation: Lessons from normal development and the response to outlet obstruction
30. Pharmacologic treatment of voiding dysfunction
31. Terazosin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia
32. Calcium fluxes, calcium antagonists, and calcium related pathology in brain ischemia, hypoglycemia, and spreading depression: Unifying hypothesis
33. Reperfusion of rat heart after brief ischemia induces proteolysis of calspectin (nonerythroid spectrin or fodrin) by calpain
34. Calcium channel antagonists prevent urinary bladder growth and neuroplasticity following mechanical stress
35. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): A multicentre trial in central Europe
36. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostatic hyperplasia: A randomized international study of 1098 patients
37. Placebo-controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after exclusion of placebo responders
38. Protective effect of Tadenan on bladder function secondary to partial outlet obstruction
39. Beneficial effects of Tadenan therapy following two weeks of partial outlet obstruction in the rabbit
40. Indigocarmine as a quantitative indicator of urothelial integrity
41. Trypan blue as an indicator of urothelial integrity